Estimation of an Optimal Chemotherapy Utilisation Rate for Upper Gastrointestinal Cancers: Setting an Evidence-Based Benchmark for the Best-Quality Cancer Care

Aims. The proportion of patients with upper gastrointestinal cancers that received chemotherapy varies widely in Australia and internationally, indicating a need for a benchmark rate of chemotherapy utilisation. We developed evidence-based models for upper gastrointestinal cancers to estimate the op...

Descripción completa

Detalles Bibliográficos
Autores principales: Ng, Weng, Jacob, Susannah, Delaney, Geoff, Do, Viet, Barton, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4391697/
https://www.ncbi.nlm.nih.gov/pubmed/25883645
http://dx.doi.org/10.1155/2015/753480

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4391697/
https://www.ncbi.nlm.nih.gov/pubmed/25883645
http://dx.doi.org/10.1155/2015/753480

Ejemplares similares